IP Library › Granted Patent US 11,286,470
Granted Patent B2
US 11,286,470 · App. 16/852,592 · Granted Mar 29, 2022

Mutant Cas9 proteins

Inventors: Alejandro Chavez (New York, NY); Frank J. Poelwijk (Dallas, TX); George M. Church (Brookline, MA)
Assignee: President and Fellows of Harvard College
C12N9/22C07H21/04C12Q1/6897C12Y301/00G01N33/573G01N2333/922
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,286,470
App. No.
16/852,592
Granted
Mar 29, 2022
Kind
B2
Abstract

Methods of making mutant Cas9 proteins are described.

Claims (16)

1. A method of making a mutant Cas9 protein comprising

identifying one or more amino acid sequences within a family of Cas9 proteins that are not highly conserved or have low conservation, wherein the one or more amino acid sequences that are not highly conserved or have low conservation are identified by obtaining a sequence alignment of multiple Cas9 amino acid sequences, and by identifying stretches of low conservation or stretches between conservation edges, wherein the conservation of said amino acid sequences is calculated as the relative entropy of amino acid frequencies per position,

identifying a nucleic acid sequence encoding the one or more identified amino acid sequences,

generating a nucleic acid sequence encoding a target Cas9 protein which lacks the nucleic acid sequence encoding the one or more identified amino acid sequences, and

generating a mutant Cas9 protein from the generated nucleic acid sequence, wherein the mutant Cas9 protein retains DNA binding activity.

2. The method of claim 1 wherein the target Cas9 protein has nuclease activity.

3. The method of claim 1 wherein the target Cas9 protein is a nickase.

4. The method of claim 1 wherein the target Cas9 protein is nuclease null.

5. The method of claim 1 wherein the nucleic acid sequence encoding the one or more identified amino acid sequences is deleted from a nucleic acid sequence encoding the target Cas9 protein.

6. The method of claim 1 wherein the nucleic acid sequence encoding the one or more identified amino acid sequences is deleted from a nucleic acid sequence encoding the target Cas9 protein and replaced with a linker.

7. The method of claim 1 wherein the nucleic acid sequence encoding the one or more identified amino acid sequences is deleted from a nucleic acid sequence encoding the target Cas9 protein and replaced with a SGGGS linker.

8. The method of claim 1 wherein the method further comprises

identifying one or more amino acid sequences within a family of Cas9 proteins that are of either high conservation or low conservation wherein each of the high or low conservation sequences is flanked by two flanking amino acid sequences of either low conservation or high conservation, respectively.

9. The method of claim 8 wherein each of the one or more amino acid sequences has a pair of edge amino acid sequences distinguishing the one or more amino acid sequences from flanking amino acid sequences.

10. The method of claim 1 wherein the mutant Cas9 protein is a mutant Cas9 protein encoded by the nucleic acid sequence of SEQ ID NO:1.

11. The method of claim 1 wherein the mutant Cas9 protein is a mutant Cas9 protein encoded by the nucleic acid sequence of SEQ ID NO:2.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2021
From: CHAVEZ, ALEJANDRO; POELWIJK, FRANK J.; CHURCH, GEORGE M.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 058251/0267 →
Continuity (5)
Continuation 16440241 · Jun 13, 2019
Continuation 16157481 · Oct 11, 2018
Division 15037696
Provisional Application 61906374 · Nov 19, 2013
Related Publication 20200283747A1 · Sep 10, 2020
Cited By (2)
US 12,201,699 US 12,251,429